These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 37338666)

  • 1. Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know.
    Marano P; Wei J; Merz CNB
    Curr Atheroscler Rep; 2023 Aug; 25(8):435-446. PubMed ID: 37338666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction.
    Lee SH; Shin D; Lee JM; van de Hoef TP; Hong D; Choi KH; Hwang D; Boerhout CKM; de Waard GA; Jung JH; Mejia-Renteria H; Hoshino M; Echavarria-Pinto M; Meuwissen M; Matsuo H; Madera-Cambero M; Eftekhari A; Effat MA; Murai T; Marques K; Doh JH; Christiansen EH; Banerjee R; Kim HK; Nam CW; Niccoli G; Nakayama M; Tanaka N; Shin ES; Chamuleau SAJ; van Royen N; Knaapen P; Koo BK; Kakuta T; Escaned J; Piek JJ;
    J Am Heart Assoc; 2022 May; 11(9):e025171. PubMed ID: 35475358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemia and no obstructive coronary arteries (INOCA): A narrative review.
    Mehta PK; Huang J; Levit RD; Malas W; Waheed N; Bairey Merz CN
    Atherosclerosis; 2022 Dec; 363():8-21. PubMed ID: 36423427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary electrocardiogram detects coronary microvascular dysfunction and ischemia in patients with no obstructive coronary arteries disease.
    Cevik E; Tas A; Demirtakan ZG; Damman P; Alan Y; Broyd CJ; Ozcan A; Simsek DH; Sonsoz MR; Royen NV; Perera D; Davies JE; Umman S; Sezer M
    Am Heart J; 2024 Apr; 270():62-74. PubMed ID: 38278503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary Microvascular Dysfunction.
    Vancheri F; Longo G; Vancheri S; Henein M
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32899944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Therapies for Microvascular Disease.
    Bland A; Chuah E; Meere W; Ford TJ
    Cardiol Clin; 2024 Feb; 42(1):137-145. PubMed ID: 37949535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary Microvascular Disease in Contemporary Clinical Practice.
    Smilowitz NR; Toleva O; Chieffo A; Perera D; Berry C
    Circ Cardiovasc Interv; 2023 Jun; 16(6):e012568. PubMed ID: 37259860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary Microvascular Dysfunction: A Practical Approach to Diagnosis and Management.
    Bechsgaard DF; Prescott E
    Curr Atheroscler Rep; 2021 Jul; 23(9):54. PubMed ID: 34268637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Coronary Artery Disease: Assessing the Microcirculation.
    Pruthi S; Siddiqui E; Smilowitz NR
    Rheum Dis Clin North Am; 2024 Aug; 50(3):519-533. PubMed ID: 38942582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Therapies for Microvascular Disease.
    Bland A; Chuah E; Meere W; Ford TJ
    Interv Cardiol Clin; 2023 Jan; 12(1):131-139. PubMed ID: 36372457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond Coronary Artery Disease: Assessing the Microcirculation.
    Pruthi S; Siddiqui E; Smilowitz NR
    Cardiol Clin; 2024 Feb; 42(1):125-135. PubMed ID: 37949533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemia but no obstructive coronary artery disease: more than meets the eye.
    Patel N; Greene N; Guynn N; Sharma A; Toleva O; Mehta PK
    Climacteric; 2024 Feb; 27(1):22-31. PubMed ID: 38224068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
    Rush CJ; Berry C; Oldroyd KG; Rocchiccioli JP; Lindsay MM; Touyz RM; Murphy CL; Ford TJ; Sidik N; McEntegart MB; Lang NN; Jhund PS; Campbell RT; McMurray JJV; Petrie MC
    JAMA Cardiol; 2021 Oct; 6(10):1130-1143. PubMed ID: 34160566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of coronary microvascular dysfunction.
    Bairey Merz CN; Pepine CJ; Shimokawa H; Berry C
    Cardiovasc Res; 2020 Mar; 116(4):856-870. PubMed ID: 32087007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary microvascular disease in women: epidemiology, mechanisms, evaluation, and treatment.
    Steinberg RR; Dragan A; Mehta PK; Toleva O
    Can J Physiol Pharmacol; 2024 Oct; 102(10):594-606. PubMed ID: 38728748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nonobstructive coronary stenosis on coronary microvascular dysfunction and long-term outcomes in patients with INOCA.
    Mohammed AA; Zhang H; Abdu FA; Liu L; Singh S; Lv X; Shi T; Mareai RM; Mohammed AQ; Yin G; Zhang W; Xu Y; Che W
    Clin Cardiol; 2023 Feb; 46(2):204-213. PubMed ID: 36567512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of coronary microvascular dysfunction.
    Crea F; Montone RA
    Vascul Pharmacol; 2023 Dec; 153():107239. PubMed ID: 37898380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Therapies for Microvascular Disease.
    Bland A; Chuah E; Meere W; Ford TJ
    Heart Fail Clin; 2024 Jan; 20(1):91-99. PubMed ID: 37953025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype-based management of coronary microvascular dysfunction.
    Ang DTY; Berry C; Kaski JC
    J Nucl Cardiol; 2022 Dec; 29(6):3332-3340. PubMed ID: 35672569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular circumferential strain and coronary microvascular dysfunction: A report from the Women's Ischemia Syndrome Evaluation Coronary Vascular Dysfunction (WISE-CVD) Project.
    Tamarappoo B; Samuel TJ; Elboudwarej O; Thomson LEJ; Aldiwani H; Wei J; Mehta P; Cheng S; Sharif B; AlBadri A; Handberg EM; Petersen J; Pepine CJ; Nelson MD; Bairey Merz CN
    Int J Cardiol; 2021 Mar; 327():25-30. PubMed ID: 33202262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.